University Hospitals Birmingham NHS Foundation Trust

Chapters

Status Drug name NICE TAs Comments
Status: Amber Aliskiren tablets
Status: Red Bosentan tablets

Hospital only. NHS England commissioned.

Status: Green Candesartan tablets
Status: Amber Captopril tablets

For existing patients only

Status: Red Clonidine injection

Hospital use only

Status: Amber Clonidine tablets
Status: Green Doxazosin tablets
Status: Amber Enalapril tablets

For existing patients only

Status: Red Hydralazine injection

Hospital only.

Status: Green Hydralazine tablets

Hydroxyzine (Atarax, Ucerax): risk of QT interval prolongation and Torsade de Pointes

Status: Red Iloprost nebules

Hospital use only. NHS England commissioned.

Status: Green Irbesartan tablets
Status: Green Lisinopril tablets
Status: Green Losartan tablets
Status: Amber Methyldopa tablets
Status: Red Metirsoine

Hospital use only

Status: Amber Minoxidil tablets
Status: Amber Moxonidine tablets
Status: Green Perindopril erbumine tablets
Status: Amber Phenoxybenzamine capsules
Status: Red Phentolamine Messilate injection 10mg/ml (Rogitine®)

Unlicensed

Status: Green Ramipril capsules

Ramipril (as capsules) has the most robust evidence base and is considered to be the first line agent of choice.

Status: Amber Sacubitril/Valsartan (Entresto®)

RICaD. Transfer to primary care at three months following initiation by Heart Failure specialist supported by a RICaD.

Status: Red Sildenafil injection

Hospital use only. NHS England commissioned.

Status: Red Sildenafil tablets

Hospital use only. NHS England commissioned.

Status: Red Sodium nitroprusside injection

Hospital use only

Status: Red Trimetaphan camsilate

Hospital use only

Status: Green Valsartan capsules
Building healthier lives
Back to top